Sparano JA - Search Results

1

Clinical application of gene expression profiling in breast cancer.

Sparano JA, Fazzari M, Kenny PA. Sparano JA, et al. Surg Oncol Clin N Am. 2010 Jul;19(3):581-606. doi: 10.1016/j.soc.2010.03.008. Surg Oncol Clin N Am. 2010. PMID: 20620929 Review.

2

Urinary estrogen metabolites and breast cancer: a case-control study.

Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, Rosenblatt R, Bradlow HL. Kabat GC, et al. Among authors: sparano ja. Cancer Epidemiol Biomarkers Prev. 1997 Jul;6(7):505-9. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9232337

3

Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma.

Iskaros BF, Hu X, Sparano JA, Fineberg SA. Iskaros BF, et al. Among authors: sparano ja. J Surg Oncol. 1998 Jun;68(2):107-12. doi: 10.1002/(sici)1096-9098(199806)68:2<107::aid-jso7>3.0.co;2-a. J Surg Oncol. 1998. PMID: 9624040

4

Microvessel density and p53 overexpression in young women with breast cancer: a case-control study.

Kalfon B, Fineberg S, Gu Y, Anand K, Dalal A, Jones J, Sparano JA. Kalfon B, et al. Among authors: sparano ja. Clin Breast Cancer. 2001 Apr;2(1):67-72. doi: 10.3816/CBC.2001.n.013. Clin Breast Cancer. 2001. PMID: 11899385

5

Clinical application of molecular profiling in breast cancer.

Sparano JA, Fazzari MJ, Childs G. Sparano JA, et al. Future Oncol. 2005 Aug;1(4):485-96. doi: 10.2217/14796694.1.4.485. Future Oncol. 2005. PMID: 16556025 Review.

6

Development of the 21-gene assay and its application in clinical practice and clinical trials.

Sparano JA, Paik S. Sparano JA, et al. J Clin Oncol. 2008 Feb 10;26(5):721-8. doi: 10.1200/JCO.2007.15.1068. J Clin Oncol. 2008. PMID: 18258979 Review.

7

Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.

Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, Sledge GW Jr, Perez EA, Shulman LN, Martino S, Sparano JA. Goldstein LJ, et al. Among authors: sparano ja. J Clin Oncol. 2008 Sep 1;26(25):4063-71. doi: 10.1200/JCO.2007.14.4501. Epub 2008 Aug 4. J Clin Oncol. 2008. PMID: 18678838 Free PMC article. Clinical Trial.

8

Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.

Sparano JA, Moulder S, Kazi A, Coppola D, Negassa A, Vahdat L, Li T, Pellegrino C, Fineberg S, Munster P, Malafa M, Lee D, Hoschander S, Hopkins U, Hershman D, Wright JJ, Kleer C, Merajver S, Sebti SM. Sparano JA, et al. Clin Cancer Res. 2009 Apr 15;15(8):2942-8. doi: 10.1158/1078-0432.CCR-08-2658. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351752 Free PMC article. Clinical Trial.

9

Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.

Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RL. Sparano JA, et al. Breast Cancer Res Treat. 2010 Apr;120(2):273-84. doi: 10.1007/s10549-009-0655-z. Epub 2009 Dec 19. Breast Cancer Res Treat. 2010. PMID: 20024613 Review.

10

Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.

Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW Jr, Gray R. Sparano JA, et al. Clin Cancer Res. 2011 Nov 15;17(22):7194-203. doi: 10.1158/1078-0432.CCR-10-3357. Epub 2011 Sep 20. Clin Cancer Res. 2011. PMID: 21933890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters